Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 12,801 | 6,814 | 6,516 | 3,578 | 68,927 |
| Cost of Goods | 2,010 | 1,327 | 1,380 | 1,092 | 1,590 |
| Gross Profit | 10,791 | 5,487 | 5,136 | 2,486 | 67,337 |
| Operating Expenses | 36,167 | 29,352 | 27,487 | 22,444 | 28,021 |
| Operating Income | -25,366 | -23,538 | -21,971 | -19,866 | 39,906 |
| Interest Expense | 1,735 | 1,747 | 1,758 | 1,768 | 1,778 |
| Other Income | 34,581 | 30 | 270 | 4,434 | 1,972 |
| Pre-tax Income | 7,480 | -25,255 | -23,459 | -17,200 | 40,100 |
| Net Income Continuous | 7,480 | -25,255 | -23,459 | -17,200 | 40,100 |
| Net Income | $7,480 | $-25,255 | $-23,459 | $-17,200 | $40,100 |
| EPS Basic Total Ops | 0.30 | -1.20 | -1.00 | -0.80 | 1.80 |
| EPS Basic Continuous Ops | 0.34 | -1.15 | -1.08 | -0.79 | 1.84 |
| EPS Diluted Total Ops | 0.30 | -1.20 | -1.00 | -0.80 | 1.80 |
| EPS Diluted Continuous Ops | 0.33 | -1.15 | -1.02 | -0.79 | 1.79 |
| EBITDA(a) | $-23,015 | $-21,331 | $-19,803 | $-17,835 | $41,962 |